ArticlebioRxiv : the preprint server for biology2025
Glucocorticoids regulate small extracellular vesicle (sEV) release via activation of nSMase2.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
2 authors.
Funding
Abstract
Chronic stress, marked by prolonged elevation of glucocorticoid (GC) stress hormones, is a major risk factor for Alzheimer's disease (AD) and accelerates AD pathology in mouse models. A key mechanism contributing to AD progression is the release of small extracellular vesicles (sEVs) carrying pathogenic proteins (e.g., tau, amyloid-beta) between brain regions, but the role of GCs in sEV biogenesis and release is unknown. Using total internal reflection fluorescence (TIRF) microscopy and the pH-sensitive marker mCh-CD63-pHluorin to visualize sEV release, we show that GCs stimulate sEV secretion in a neuronal cell line. This process requires the GTPase Rab27a and the enzyme neutral sphingomyelinase 2 (nSMase2), which catalyzes ceramide production and drives sEV formation. We further demonstrate that GCs promote sEV release by activating nSMase2 downstream of mitochondrial reactive oxygen species production and opening of the mitochondrial permeability transition pore (mPTP). These findings link GC-induced mitochondrial damage, specifically mPTP opening, to nSMase2 activation and enhanced sEV release by neuronal cells.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.